Genetesis CardioFlux™ platform receives FDA 510(k) clearance
/
DateMar 22 2019
(Mason, OH March 22, 2019 8 am) Genetesis, a medical technology company focused on using biomagnetic imaging to enable rapid, noninvasive and accurate chest pain... Read More →















